The following column was originally published May 28, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Progressive and incurable, Alzheimer’s disease affects an estimated 6.7 million U.S. adults at least 65 years old, according ...

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

The team asserted that such wellbeing levels not only improved self confidence and happiness, but had the potential to boost life expectancy ... Professor of Dementia Research at the University ...

The study found that delaying dementia onset by five years could add an extra three years to life expectancy, while also significantly reducing healthcare costs – potentially saving as much as ...

Leading a socially active life as one ages may help delay the onset of dementia. Activities like bingo nights, dining with friends, and attending religious services can promote social connections ...

A daily pill costing as little as one pence could help lower your risk of dementia, scientists have said. According to a study, vitamin D supplementation is linked to lower incidence of the ...

Live life through the eyes and actions of Henry, a young man on a quest to avenge his murdered parents. His story—illustrated with over five hours of stunning cinematics—takes him from ...

A study published in Neurology found that older adults with fluctuating cholesterol levels have a higher risk of developing dementia. The research involved 9,846 participants, highlighting that ...

This week's topics include neuropathy after chemotherapy, a comprehensive approach to dementia care, mortality and falls, and life expectancy and educational attainment. Rick: And life expectancy ...

The researchers point out that a five-year delay in dementia onset could result in approximately $500,000 in healthcare savings per person, while potentially adding three years to life expectancy ...

Cognition Therapeutics, Inc. announced promising results from the SHIMMER study of zervimesine (CT1812) in patients with mild-to-moderate dementia with Lewy bodies (DLB), to be presented by Dr ...